The work provides an insight for rational design and optimization of the heated nanoprobe/surface configuration-based systems for topography applications. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3054549]“
“Objective: To identify the components of a human papillomavirus (HPV) ON-01910 mw message contributing to reducing the stigma of HPV
in cervical cancer.
Methods: 294 ethnic Chinese women attending a community-based clinic in Hong Kong were randomly allocated to read one of three written HPV messages: Group ‘lr+hrHPV’: low-risk and high-risk HPVs facts, Group ‘hrHPV’: high-risk HPV facts only and Group ‘ds+hrHPV’: high-risk HPV facts and de-stigmatising components, namely being anti-stereotypical, motivational and low
in complexity. Main outcome measures were high-risk HPV-related sexual stigma, knowledge, attitude towards message, and intention to be HPV-tested measured by self-administered questionnaires immediately before and after reading.
Results: Message allocation had a significant effect on sexual stigma (F = 5.219, p = 0.006). Participants who read message ds+hrHPV showed the least stigma, and were significantly less likely to believe that high-risk HPV infection implicated promiscuity, non-monogamy or that monogamy offered complete protection against high-risk HPV. The genital HPV-focused message was more GSK2118436 chemical structure stigmatising than cervical cancer-focused messages. Of all participants, find more 93% (237/254) and 97% (260/269) indicated a positive intention to be HPV-tested before and after reading, respectively. There were no between-group differences noted in terms of knowledge and intention to be HPV-tested before or after reading.
Conclusions: Our findings show that an HPV message containing specific de-stigmatising components may reduce public stigma towards high-risk HPV. Also,
focusing solely on high-risk HPV in the context of cervical cancer helps to avoid the stigmatising effect of genital warts from tainting perceptions about high-risk HPV infection. Copyright (C) 2010 John Wiley & Sons, Ltd.”
“Growth failure is almost inextricably linked with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Growth failure in CKD has been associated with both increased morbidity and mortality. Growth failure in the setting of kidney disease is multifactorial and is related to poor nutritional status as well as comorbidities, such as anemia, bone and mineral disorders, and alterations in hormonal responses, as well as to aspects of treatment such as steroid exposure. This review covers updated management of growth failure in these children including adequate nutrition, treatment of metabolic alterations, and early administration of recombinant human growth hormone (GH).